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Conclusions
The combination of CTA and perfusion correctly identifies patients
with flow limiting CAD definedas ≥ 50 stenosis by ICAcausing aper-
fusion defect by SPECT/MPI. The exclusion of patients with previous
myocardial infarction or knownCAD increased the diagnostic power
of combined CTA–CTP in the non-invasive detection of flow limiting
CAD defined by ICA-SPECT/MPI.
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A 61-year-old gentleman underwent coronary computed tomography (CT)
angiography (CCTA) for atypical chest pain, which revealed partially ectatic,
diffusely diseased coronary arteries and a giant, eccentric, and partially
thrombosed aneurysm in the proximal segment of the right coronary
artery (RCA)(size:7 × 5.5 × 6 cm;PanelsAandB, arrows).On invasiveangi-
ography, the true size of the aneurysm was underestimated due to extensive
thrombosis (Panels B andE, asteriskmarkingperfused part). Theperfused an-
eurysm was connected to the RCA through a thin neck (Panel B, arrowhead),
resembling a pseudoaneurysm rather than a true aneurysm. Myocardial per-
fusion SPECT revealed a non-transmural inferior scar without reversible is-
chaemia (Panel D: Hybrid SPECT/CT, black arrows).
Exclusion of the RCA aneurysm was performed by placement of a 4.8 ×
26 mm covered stent (Graftmaster RX, Abbott Vascular, Abbott Park, IL,
USA). Distal diameter mismatch was corrected by post-dilatation with an
oversized balloon-catheter (Avion Plus 6.0/20 mm, Medtronic Invatec,
Frauenfeld, Switzerland) (Panel F). Repeat CCTA 4 months later showed
a fully excluded aneurysm without further extravasation of contrast
(Panel C). Triple therapy with aspirin, clopidogrel, and phenprocoumon
was started for 3 months, followed by clopidogrel and phenprocoumon for another 9 months.
Coronary artery aneurysms, particularly of such giant dimensions, are rare findings on coronary angiograms and may be associated with
extensive atherosclerosis or a history of vascular inflammatory disease (e.g. Kawasaki syndrome). Spontaneous ruptures of coronary
aneurysms are exceedingly rare. However, due to the paucity of data, there is no evidence for the best treatment of such a giant aneurysm.
In this particular case, the decision to exclude the aneurysm with a covered stent was taken to avoid rupture and distal embolization.
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